Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to observe
Many biotech stocks struggled in 2023 despite a strong yr for U.S. drug approvals. As these latest therapies begin treating ...
Tag: dealmaking
JPMorgan deal-making flurry being scrutinized: report
JPMorgan Chase is being scrutinized by US regulators for the due diligence the bank conducted on plenty of its past acquisitions, the Financial ...
